Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,299 | 33,993 | 36,352 | 37,249 | 40,590 |
| Marketable Securities | N/A | 900 | 950 | 1,999 | N/A |
| Other current assets | 392 | 520 | 200 | 119 | 239 |
| TOTAL | $31,691 | $35,413 | $37,502 | $39,367 | $40,829 |
| Non-Current Assets | |||||
| PPE Net | 215 | 228 | 242 | 256 | 65 |
| Other Non-Current Assets | 12 | 12 | 12 | 12 | 12 |
| TOTAL | $227 | $240 | $254 | $268 | $77 |
| Total Assets | $31,918 | $35,653 | $37,756 | $39,635 | $40,906 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,034 | 898 | 465 | 255 | 173 |
| Accrued Expenses | 1,517 | 1,688 | 1,348 | 945 | 677 |
| TOTAL | $2,551 | $2,586 | $1,813 | $1,200 | $850 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,551 | $2,586 | $1,813 | $1,200 | $850 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,539 | 6,539 | 6,539 | 6,539 | 6,539 |
| Common Shares | 46 | 46 | 46 | 46 | 46 |
| Retained earnings | -130,638 | -126,121 | -122,450 | -119,076 | -116,493 |
| Other shareholders' equity | 0 | 1 | 1 | 1 | 1 |
| TOTAL | $29,367 | $33,067 | $35,943 | $38,435 | $40,056 |
| Total Liabilities And Equity | $31,918 | $35,653 | $37,756 | $39,635 | $40,906 |